Histologic features of mammary carcinomas in zoo felids treated with melengestrol acetate (MGA) contraceptives

Veterinary Pathology

Volumn 44, Issue 3, 2007, Pages 320-326

  McAloose, D ^a,b   Munson, L ^a   Naydan, D K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WILDLIFE CONSERVATION SOCIETY   (United States)

Author keywords

Cat; Felidae; Mammary carcinoma; Melengestrol acetate; Progesterone receptor

Indexed keywords

CONTRACEPTIVE AGENT; ESTROGEN RECEPTOR; MELENGESTROL ACETATE; PROGESTERONE RECEPTOR;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; METABOLISM; MORALITY; PANTHERA; PATHOLOGY;

ANIMALS; CONTRACEPTIVE AGENTS; GENE EXPRESSION REGULATION, NEOPLASTIC; MAMMARY NEOPLASMS, ANIMAL; MELENGESTROL ACETATE; PANTHERA; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE MORAL JUDGMENT;

FELIDAE;

EID: 34249003020     PISSN: 03009858     EISSN: 15442217     Source Type: Journal    
DOI: 10.1354/vp.44-3-320     Document Type: Article

References (42)

1. Black D, Seal US, Plotka ED, Kitchen H: Uterine biopsy of a lioness and a tigress after melengestrol implant. J Zoo Anim Med 10:53-56, 1979
2. Blanco G, Alavaikko M, Ojala A, Collan Y, Heikkinen M, Hietanen T, Aine R, Taskinen PJ: Estrogen and progesterone receptors in breast cancer: relationships to tumor histopathology and survival of patients. Anticancer Res 4:383-390, 1984
3. Bocchinfuso WP, Korach KS: Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J Mammary Gland Biol Neoplasia 2:323-334, 1997
4. Brower ST, Cunningham JD, Tartter PI: Hormonal Influences on Oncogenesis and Growth. In: Breast Cancer, p. 688. Churchill Livingston, Philadelphia, PA, 1999
5. Castagnaro M, Casalone C, Bozzetta E, DeMaria R, Biolatti B, Caramelli M: Tumour grading and the one-year post-surgical prognosis in feline mammary carcinoma. J Comp Pathol 119:263-275, 1998
6. Clark JH, Mani SK: Actions of ovarian steroid hormones. In: The Physiology of Reproduction, ed. Knobil E and Neill JD, 2nd ed., pp. 1011-1059. Raven Press, New York, NY, 1994
7. Cunha GR, Wiesen JF, Werb Z, Young P, Hom YK, Cooke PS, Lubahn DB: Paracrine mechanisms of mouse mammary ductal growth. Adv Exp Med Biol 480:93-97, 2000
8. DeVico G, Maiolino P: Prognostic value of nuclear morphometry in feline mammary carcinoma. J Comp Pathol 117:99-105, 1997
9. Dorn AS, Legendre AM, McGavin MD: Mammary hyperplasia in a male cat receiving progesterone. J Am Vet Med Assoc 182:621-622, 1983
10. Duncan GW, Lyster SC, Hendrix JW, Clark JJ, Webster HD: Biologic effects of melengestrol acetate. Fertil Steril 15:419-432, 1964
11. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer - experience from a large study with long-term follow-up. Histopathology 19:403-410, 1991
12. Harrenstien LA, Munson L, Seal US: Mammary cancer in captive wild felids and risk factors for its development: a retrospective study of the clinical behavior of 31 cases. J Zoo Wildl Med 27:468-476, 1996
13. Hayden DW, Barnes DM, Johnson KH: Morphologic changes in the mammary gland of megestrol acetate-treated and untreated cats: a retrospective study. Vet Pathol 26:104-113, 1989
14. Hayes HM, Milne KL, Mandell CP: Epidemiologic features of feline mammary carcinoma. Vet Rec 108:476-479, 1981
15. Hernandez FJ, Fernandez BB, Chertack M, Gage PA: Feline mammary carcinoma and progestogens. Feline Pract 5:45-48, 1975
16. Hinton M, Gaskell CJ: Non-neoplastic mammary hypertrophy in the cat associated either with pregnancy or with oral progestagen therapy. Vet Rec 100:277-280, 1977
17. Hopp TA, Fuqua SA: Estrogen and progesterone receptors in breast cancer. In: Encyclopedia of Hormones, ed. Henry HL and Norman AW, pp. 573-577. Elsevier Inc., San Diego, CA, 2003
18. Hruban Z, Carter WE, Meehan T, Wolff P, Franklin WA, Glagov S. Complex mammary carcinoma in a tiger (Panthera tigris). J Zoo Anim Med 19:226-230, 1988
19. Imagawa W, Yang J, Guzman R, Nandi S: Control of mammary gland development. In: The Physiology of Reproduction, ed. Knobil E and Neill JD, pp. 1033-1063. Raven Press, New York, NY, 1994
20. Ito T, Kadosawa T, Mochizuki M, Matsunaga S, Nishimura R, Sasaki N: Prognosis of malignant mammary tumor in 53 cats. J Vet Med Sci 58:723-726, 1996
21. Johnson P, Baffa D: Use of megestrol acetate in African lions (Panthera leo). Vet Med Small Anima Clin 74:1542-1544, 1979
22. Johnston SH, Hayden DW, Kiang DT, Handschin B, Johnson KH: Progesterone receptors in feline mammary adenocarcinoma. Am J Vet Res 45:379-382, 1984
23. Kazensky CA, Munson L, Seal US: The effects of melengestrol acetate on the ovaries of captive wild cats. J Zoo Wildl Med 29:1-5, 1998
24. Loretti AP, Ihla MR, Ordas j, Martin de las Mulas J: Clinical, pathological and immunohistochemical study of feline mammary fibroepithelial hyperplasia following a single injection of depot medroxyprogesterone acetate. J Feline Med Surg 7:43-52, 2005
25. Martin de las Mulas J, Millan Y, Bautista MJ, Perez J, Carrasco L: Oestrogen and progesterone receptors in feline fibroadenomatous change: an immunohistochemical study. Res Vet Sci 68:15-21, 2000
26. Martin de las Mulas J, van Niel M, Millan Y, Blankenstein MA, van Mil F, Misdorp W: Immunohistochemical analysis of estrogen receptors in feline mammary gland benign and malignant lesions: comparison with biochemical assay. Domest Anim Endocrinol 18:111-125, 2000
27. Martin PM, Cotard M, Mialot JP, Andre F, Raynaud JP: Animal models for hormone-dependent human breast cancer: a relationship between steroid receptor profiles in canine and feline mammary tumors and survival rate. Cancer Chemother Pharmacol 12:13-17, 1984
28. Millanta F, Lazzeri G, Mazzei M, Vannozzi I, Poli A: MIB-1 labeling index in feline dysplastic and neoplastic mammary lesions and its relationship with postsurgical prognosis. Vet Pathol 39:120-126, 2002
29. Misdorp W: Progestagens and mammary tumors in dogs and cats. Acta Endocrinol (Copenh) 125(Suppl 1): 27-31, 1991
30. Misdorp W, Else RW, Hellman E, Lipscomb TP: Histologic Classification of Mammary Tumors of the Dog and the Cat, vol. VII, p. 58. Armed Forces Institute of Pathology, Washington, DC, 1999
31. Nagasawa H, Sakagami N, Ohbayashi R, Yamamoto K, Petrow V: Effect of megestrol acetate or melengestrol acetate on preneoplastic and neoplastic mammary growth in mice. Anticancer Res 8:1399-1404, 1988
32. Romatowski J: Use of megestrol acetate in cats. J Am Vet Med Assoc 194, 700-702, 1989
33. Rutteman GR, Blankenstein MA, Minke J, Misdorp W: Steroid receptors in mammary tumors of the cat. Acta Endocrinol 125(Suppl 1): 32-37, 1991
34. Seal US, Barton R, Mather L, Olberding K, Plotka ED, Gray CW: Hormonal contraception in captive female lions (Panthera leo). J Zoo Anim Med 7:12-20, 1976
35. Shyamala G: Progesterone signaling and mammary gland morphogenesis. J Mammary Gland Biol Neoplasia 4:89-104, 1999
36. Shyamala G, Yang X, Cardiff RD, Dale E: Impact of progesterone receptor on cell-fate decisions during mammary gland development. Proc Natl Acad Sci U S A 97:3044-3049, 2000
37. Siegel S, Castellan NJ: Nonparametric statistics for the behavioral sciences, 2 ed. p. 399. McGraw-Hill, New York, NY, 1988
38. Singh L, Wilson AJ, Baum M, Whimster WF, Birch IH, Jackson IM, Lowrey C, Palmer MK: The relationship between histological grade, estrogen receptor status, events and survival at 8 years in the NATO (Nolvadex) trial. Br J Cancer 57:612-614, 1988
39. Steeg PS, Hartsough MT, Clare SE: Nm23, Breast Differentiation, and Cancer Metastasis, 2nd ed., p. 582. Humana Press, Totowa, NJ, 1999
40. Sud SC, Meites J: Effect of melengestrol acetate on the organ weight and the mammary lobulo-alveolar development in rats. Indian J Exp Biol 9:138-141, 1971
41. Weigel NL, Rowan BG: Estrogen and progesterone action. In: Endocrinology, ed. Marshall JC, 4th ed., pp. 2053-2060. WB Saunders, Philadelphia, PA, 2001
42. Weijer K, Head KW, Misdorp W, Hampe JF: Feline malignant mammary tumors. I. Morphology and biology - some comparisons with human and canine mammary carcinomas. J Natl Cancer Inst 49:1697-1704, 1972